Malaria
Pf/Pan Antigen Rapid Test Kit (Colloidal Gold)
[Product Name]
General name: Malaria Pf/Pan Antigen
Rapid Test Kit (Colloidal Gold)
【Packing Specification】
25 persons/box
【Intended
Use】
It is suitable for
qualitative detection of Pf-specific lactate dehydrogenase of Plasmodium
falciparum (Pf-LDH) and Pan-specific lactate dehydrogenase LDH of Plasmodium
panparum (Pan-LDH) in human whole blood samples in vitro.
【Test
Principle】
This product uses
immunochromatographic technology to detect Malaria Pf/Pan Antigen by double
antibody sandwich method. During detection, the sample is dropwise added into a
sampling well of the test card. When a sample to be detected contains Pf-LDH
and Pan-LDH antigens and the antigen concentration is higher than a minimum detection
limit, the Pf-LDH and Pan-LDH antigens and the labeled antibody form a reaction
complex firstly, which moves forward along the nitrocellulose membrane under
the chromatographic action, and captured by monoclonal antibodies to
anti-Pf-LDH and anti-Pan-LDH in detection zones (2) and (or)(1) of the nitrate
fiber membrane, respectively, and finally forms a red/pink reaction line in the
detection zone (2) and (or) zone (1) without influenza A, the result is
positive at this time. Conversely, when the samples are free of Pf-LDH and (or)
Pan-LDH antigens or the antigen concentration is below the minimum detection
limit, no red/pink reaction line will display in the detection zone and the
result is negative. Regardless of whether the sample contains Pf-LDH and Pan
antigen, the quality control (C) will form a red/pink reaction line. The
red/pink reaction line displayed in the quality control area (C) is the
standard to determine whether the chromatography process is normal, and also
serves as the internal control standard of the reagent.
【Main
Component】
Ingredients
|
Qty./Spec.
|
Main components:
|
Test card (with desiccant)
|
1 person/bag
|
Each detection
card is mainly composed of a plastic shell and a test strip. The
nitrocellulose membrane, the main part of the test strip, is coated with an
anti-Pf-LDH monoclonal antibody and/or an anti-Pan-LDH monoclonal antibody
and rabbit IgG. The binding pad is coated with the colloidal gold-labeled
anti-Pf-LDH monoclonal antibody and/or an anti-Pan-LDH monoclonal antibody
and the colloidal gold-labeled sheep anti-rabbit IgG antibody. Other
components include polyester film, and absorption paper, etc.
|
Sample diluent
|
25 pieces/box
|
Mainly phosphate buffer solution (PBS) (0.1 M, pH7.2±0.2).
|
[Components required for testing but
not provided]:
timer, 10ul range micropipette and associated nozzles, centrifuge
[Storage Conditions and
Validity】
This kit is kept at 2~30℃, under
sealed state of aluminum foil bag. Its shelf life is 18 months. After the
unsealing of aluminum foil bag, this kit should be used within one hour. The
sample extracts should be capped immediately after use and placed in a cool
place or refrigerator. Production date and expiry date are shown in the package
or label.
[Sample Requirements]
1.
Venous
blood collection:
a)
Collect
whole blood by venipuncture and put it into anticoagulation tube containing
EDTA. All specimens should be treated as infectious factors.
b)
Whole
blood samples should be stored at 2-8℃ for three days after collection.
c)
Samples
must be restored to room temperature before detection, and mixed evenly before
use.
2.
Fingertip
blood collection:
a)
Disinfect
the blood collection part with alcohol, squeeze the blood collection part with
fingers, and puncture the skin with a sterilized lancet to collect blood.
b)
Wipe
off the first drop of blood with sterilized gauze or cotton. Contact to collect
blood with dropper.
[Test Method]
1. Please read the instructions carefully
before testing.
2. When stored at low temperature, the
kit and collected experimental samples should be restored to room temperature
before use.
3. Aluminum foil bag is torn off. Test
card is taken out, and put flatly onto the surface of operating table.
4. Whole blood sample is drawn through
pipette separately at 10ul, and then dripped into sample injection hole of test
card. The cap of bottle for sample buffer solution enclosed in the kit is
rotated off; and the bottle for sample buffer solution is inverted. The sample
buffer solution is dripped vertically by 3 drops (about 80ul) into sample
injection hole. Then, the timing is started.
5. At 10~15 minutes, final result is
read. After 15 minutes, test result must not be read. The results displayed
after 30 minutes have no clinical significance.
6. Note: The test had better be
completed under room temperature (15~30℃).
[Interpretation
of Test Results]
Positive
for Malaria Pf: Two red/pink reaction lines appear, one in Zone 2 and one in
Zone C (quality control zone).
Positive
for Malaria Pan: Two red/pink reaction lines appear, one in Zone 1 and one in
Zone C (quality control zone).
Positive
for Malaria Pf/Pan: Three red/pink reaction lines appear, one in Zone 2, one in
Zone 1 and one in Zone C (quality control zone).
Negative:
Only one red pink reaction line appear in Zone C and no red/pink bands are
observed in Zone 2 and Zone 1.
Invalid:
In case that no red/pink reaction line appears in the quality control zone C,
the test is invalid, and it is recommended to retest with a new test card at
this time.
Note:
The color development of reaction line is related to the content of the tested
substance in the extracted sample. The result should be determined according to
whether the reaction line develops color, regardless of the color intensity.
This
reagent contains the quality control process. When a red/pink reaction line
appears in Zone C, indicating that the operation is correct and effective.
Otherwise, the detection is invalid.
Standard
Laboratory Practice (GLP) Laboratories recommend that quality control be
conducted in accordance with laboratory procedures and guided by national or
local regulations.
[Limitations of Test Method]
1.
The
kit is limited to in vitro diagnosis, and it is only used for qualitative
detection of Plasmodium falciparum Pf and Plasmodium Pan in human whole blood
samples. Please refer to the relevant professional instruments for the testing
of the specific content of an indicator.
2.
The
accuracy of the test depends on the sample collection process. Improper sample
collection, improper sample storage, stale samples, or stale samples will
affect the test results.
3.
The
test results with this reagent are for clinical reference only and cannot be
used as the only basis for clinical diagnosis and treatment. Clinical
management of patients should be comprehensively considered in reference to
their symptoms/signs, medical history, other laboratory tests, and treatment
response.
4.
Reagents
with different batch numbers cannot be mixed.
5.
Analysis
of the possibility of false negative results:
a)
Unreasonable
sample collection, transportation and treatment, and low antigen concentration
in samples may lead to false negative results.
b)
Plasmodium
genetic variation may cause antigenic determinant changes resulting in
false-negative results, which are more likely to occur with reagents that use
monoclonal antibodies.
[Product
Performance Indicators]
1.
LOD:
Pf-LDH LOD: 8pg/mL; Pan-LDH LOD: 24pg/mL.
2.
Coincidence
rate of positive reference: Compared with the results of microscopic examination,
the coincidence rate of Pf-LDH positive reference is 97.2%, and the coincidence
rate of Pan-LDH positive reference is 97.82%.
3.
Coincidence
rate of negative reference: Compared with the results of microscopic
examination, the coincidence rate of Pf-LDH negative reference is 98.16%, and
the coincidence rate of Pan-LDH negative reference is 98.67%.
4.
Intra-batch
precision: Ten test cards are randomly selected from the same batch of Pf
antigen or Pan antigen test kit products. Through the enterprise internal
control reproducibility reference material (C1 and C2), a parallel test is
made. The test results should all be positive; and the colority should be not
obviously different under macroscopic observation.
5.
Inter-batch
precision: Take three consecutive batches of products from Pf antigen or Pan
antigen detection kit products (at least three people in each batch). Through
the enterprise internal control reproducibility reference material (C1 and C2),
a parallel test is made. The test results should all be positive; and the
colority should be not obviously different under macroscopic observation.
6.
Cross-reaction:
In order to analyze the analytical specificity of the kit, 20 kinds of
pathogenic microorganisms that may exist in blood (5 kinds of bacteria such as Borrelia
burgdorferi, Leptospira hyperbola and Treponema pallidum, 5 kinds of protozoa
such as Babesia, Kuruz vertebral parasite and Leishmania donovani, and 10 kinds
of viruses such as cytomegalovirus, dengue virus, yellow fever virus and
hepatitis B virus) are detected. The results indicate that there is no cross
reaction between this kit and these pathogenic microorganisms.
7.
Interfering
substances: hemoglobin, heme and triglyceride do not interfere with this
reagent; and anticoagulants heparin, EDTA, sodium citrate and potassium oxalate
do not interfere with this reagent.
8.
Drug
effects: Drugs used to prevent or treat malaria, such as mefloquine, quinine,
flavamine, amoxicillin, cefalin, erythromycin and aspirin, have no influence on
the detection results of this kit.
[Precautions]
1.
The
kit is only use for in vitro diagnosis. Do not reuse or use expired products.
2.
Do
not eat, drink or smoke during the experiment.
3.
Wear
protective clothing and disposable gloves when operating, and note to protect
eyes.
4.
No
color bands appear on either the control or test lines, indicating that an
error occurs and the test should be repeated.
5.
Test
environment should not be at too high temperature. Test card of low-temperature
storage should first be restored to room temperature and then opened, so as to
avoid a moisture absorption.
6.
There
is a desiccant in the aluminum foil bag, which should not be taken orally.
7.
Do
not use if the aluminum foil bag is damaged or the product is damaged before
use.